Blinatumomab (Anti-CD3 & CD19) | CD markers | Read Reviews & Product Use Citations

Blinatumomab (Anti-CD3 & CD19) is a BiTE-class (bi-specific T-cell engager) constructed monoclonal antibody with unique anti-tumor efficacy. Blinatumomab enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts.

Purity & Quality Control

Batch: A317501 Purity: 99% Protein concentration: 3.49mg/ml Endotoxin Level: ＜1EU/mg

99

Choose Selective CD markers Inhibitors

Biological Activity

Description	Blinatumomab (Anti-CD3 & CD19) is a BiTE-class (bi-specific T-cell engager) constructed monoclonal antibody with unique anti-tumor efficacy. Blinatumomab enables CD3-positive T cells to recognize and eliminate CD19-positive acute lymphoblastic leukemia (ALL) blasts.

References
[1] Kantarjian H, et al. N Engl J Med. 2017;376(9):836-847.

References

[1] Kantarjian H, et al. N Engl J Med. 2017;376(9):836-847.

Product Details

CAS No.	853426-35-4
Application	Blinatumomab (Anti-CD3 & CD19)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field